Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Gurbani

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Biomedical Nanotechnology|April 14, 2011
Stable metal oxide nanoparticle formulation for toxicity studiesDeepak Gurbani, Ritesh K Shukla, Alok K Pandey, et al.
Data in Brief|March 10, 2016
Structural dataset for the fast-exchanging KRAS G13DJia Lu, John Hunter, Anuj Manandhar, et al.
Journal of Biomedical Nanotechnology|April 14, 2011
Interaction of C60 fullerene with the proteins involved in DNA mismatch repair pathwayShishir Kumar Gupta, Lokesh Baweja, Deepak Gurbani, et al.
Mutation Research|December 9, 2008
In silico studies with human DNA topoisomerase-II alpha to unravel the mechanism of in vitro genotoxicity of benzene and its metabolitesAlok Kumar Pandey, Deepak Gurbani, Mahima Bajpayee, et al.
Journal of Biomedical Nanotechnology|April 14, 2011
C60-fullerene binds with the ATP binding domain of human DNA topoiosmerase II alphaLokesh Baweja, Deepak Gurbani, Rishi Shanker, et al.
Nanotoxicology|November 4, 2011
TiO(2) nanoparticles induce oxidative DNA damage and apoptosis in human liver cellsRitesh K Shukla, Ashutosh Kumar, Deepak Gurbani, et al.
Molecular Cancer Research : MCR|June 4, 2015
Biochemical and Structural Analysis of Common Cancer-Associated KRAS MutationsJohn C Hunter, Anuj Manandhar, Martin A Carrasco, et al.
Frontiers in Molecular Biosciences|June 9, 2020
Structure and Characterization of a Covalent Inhibitor of Src KinaseDeepak Gurbani, Guangyan Du, Nathaniel J Henning, et al.
The Journal of Biological Chemistry|July 26, 2019
Structural basis of the atypical activation mechanism of KRAS<sup>V14I</sup>Asim K Bera, Jia Lu, Thomas E Wales, et al.
The Journal of Biological Chemistry|January 9, 2020
A highly selective inhibitor of interleukin-1 receptor-associated kinases 1/4 (IRAK-1/4) delineates the distinct signaling roles of IRAK-1/4 and the TAK1 kinaseScott A Scarneo, Philip F Hughes, Kelly W Yang, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Biomedical Nanotechnology|April 14, 2011
Stable metal oxide nanoparticle formulation for toxicity studiesDeepak Gurbani, Ritesh K Shukla, Alok K Pandey, et al.
Data in Brief|March 10, 2016
Structural dataset for the fast-exchanging KRAS G13DJia Lu, John Hunter, Anuj Manandhar, et al.
Journal of Biomedical Nanotechnology|April 14, 2011
Interaction of C60 fullerene with the proteins involved in DNA mismatch repair pathwayShishir Kumar Gupta, Lokesh Baweja, Deepak Gurbani, et al.
Mutation Research|December 9, 2008
In silico studies with human DNA topoisomerase-II alpha to unravel the mechanism of in vitro genotoxicity of benzene and its metabolitesAlok Kumar Pandey, Deepak Gurbani, Mahima Bajpayee, et al.
Journal of Biomedical Nanotechnology|April 14, 2011
C60-fullerene binds with the ATP binding domain of human DNA topoiosmerase II alphaLokesh Baweja, Deepak Gurbani, Rishi Shanker, et al.
Nanotoxicology|November 4, 2011
TiO(2) nanoparticles induce oxidative DNA damage and apoptosis in human liver cellsRitesh K Shukla, Ashutosh Kumar, Deepak Gurbani, et al.
Molecular Cancer Research : MCR|June 4, 2015
Biochemical and Structural Analysis of Common Cancer-Associated KRAS MutationsJohn C Hunter, Anuj Manandhar, Martin A Carrasco, et al.
Frontiers in Molecular Biosciences|June 9, 2020
Structure and Characterization of a Covalent Inhibitor of Src KinaseDeepak Gurbani, Guangyan Du, Nathaniel J Henning, et al.
The Journal of Biological Chemistry|July 26, 2019
Structural basis of the atypical activation mechanism of KRAS<sup>V14I</sup>Asim K Bera, Jia Lu, Thomas E Wales, et al.
The Journal of Biological Chemistry|January 9, 2020
A highly selective inhibitor of interleukin-1 receptor-associated kinases 1/4 (IRAK-1/4) delineates the distinct signaling roles of IRAK-1/4 and the TAK1 kinaseScott A Scarneo, Philip F Hughes, Kelly W Yang, et al.
Pageof 3